Catechol, a Bioactive Degradation Product of Salicortin, Reduces TNF-α Induced ICAM-1 Expression in Human Endothelial Cells

Abstract

The phenolic glucoside salicortin was isolated from a Willow bark extract, and its ability to reduce the TNF-α induced ICAM-1 expression (10 ng/mL, 30 min pretreatment with salicortin) was tested in vitro on human microvascular endothelial cells (HMEC-1). After 24 h, 25 µM salicortin decreased the TNF-α induced ICAM-1 expression to 65.9 % compared to cells which were treated only with TNF-α. In parallel, the stability of 25 µM salicortin under assay conditions was determined by HPLC. Within 24 h, the salicortin concentration decreased to 3.1 µM whereas catechol, a known NF-κB inhibitor, rose as a metabolite. After 8 h the catechol concentration was relatively constant and varied between 8.2 and 10.9 µM. Considering this degradation in the in vitro test system, 10 µM catechol was added 8 h after TNF-α stimulation, and 16 h later the ICAM-1 expression was determined. In this setting, the ICAM-1 expression was reduced to 74.8 %. This is comparable to the effect obtained from 25 µM salicortin and indicates that its activity is related to the generation of catechol, as salicin, saligenin, and salicylic acid are only marginally active or inactive in this test system in a concentration up to 50 µM. These results indicate catechol as an important bioactive metabolite from salicortin.

Salix - Salicaceae - salicortin - catechol

References

• 1 Mahdi J G, Mahdi A J, Mahdi A J, Bowen I D. The historical analysis of aspirin discovery, its relation to the willow tree and antiproliferative and anticancer potential.  Cell Prolif. 2006;  39 147-155
• 2 Nahrstedt A, Schmidt M, Jäggi R, Meth J, Khayyal M. Willow bark extract: the contribution to the overall effect.  Wien Med Wochenschr. 2007;  157 348-351
• 3 Schmid B, Kötter I, Heide L. Pharmacokinetics of salicin after oral administration of a standardised willow bark extract.  Eur J Clin Pharmacol. 2001;  57 387-391
• 4 RuuholaT, Julkunen-Tiitto R, Vainiotalo P. In vitro degradation of willow salicylates.  J Chem Ecol. 2003;  29 1083-1096
• 5 Zheng L T, Ryu G-M, Kwon B-M, Lee W-H, Suk K. Anti-inflammatory effects of catechols in lipopolysaccharide-stimulated microglia cells: inhibition of microglial neurotoxicity.  Eur J Pharmacol. 2008;  588 106-113
• 6 Ma Q, Kinneer K. Chemoprotection by phenolic antioxidant. Inhibition of tumor necrosis factor α induction in macrophages.  J Biol Chem. 2002;  277 2477-2484
• 7 Surh Y J, Kundu J K, Na H K. Nrf2 as a master redox switch in turning on the cellular signalling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals.  Planta Med. 2008;  74 1526-1539
• 8 Khor T O, Yu S, Kong A N. Dietary cancer chemopreventive agents – targeting inflammation and Nrf2 signaling pathway.  Planta Med. 2008;  74 1540-1547
• 9 Roebuck K A, Finnegan A. Regulation of intercellular adhesion molecule-1 (CD54) gene expression.  J Leukoc Biol. 1999;  66 876-888
• 10 Ades E W, Candal F J, Swerlick R A, George V G, Summers S, Bosse D C, Lawle T J. HMEC-1: establishment of an immortalized human microvascular endothelial cell line.  J Invest Dermatol. 1992;  99 683-690
• 11 Mosman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.  J Immunol Methods. 1983;  65 55-63

1 Dedicated to Prof. Dr. Dr. h. c. Adolf Nahrstedt on the occasion of his 70th birthday